Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system.
Market Analysis and Insights: Global Rapid Point-of-Care (PoC) Diagnostics Market
The global Rapid Point-of-Care (PoC) Diagnostics market is projected to grow from US$ 26690 million in 2024 to US$ 34550 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.
The US & Canada market for Rapid Point-of-Care (PoC) Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Rapid Point-of-Care (PoC) Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Rapid Point-of-Care (PoC) Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Rapid Point-of-Care (PoC) Diagnostics include Abbott, Roche, Danaher, Siemens Healthineers, BD, Quidel, Bio-Rad, BioMerieux and Abaxis, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Rapid Point-of-Care (PoC) Diagnostics is widely used in various fields, such as Clinics, Hospitals, Laboratory and Others, etc. Clinics provides greatest supports to the Rapid Point-of-Care (PoC) Diagnostics industry development. In 2023, global % revenue of Rapid Point-of-Care (PoC) Diagnostics went into Clinics filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Rapid Point-of-Care (PoC) Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rapid Point-of-Care (PoC) Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Rapid Point-of-Care (PoC) Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rapid Point-of-Care (PoC) Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Rapid Point-of-Care (PoC) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Rapid Point-of-Care (PoC) Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott
Roche
Danaher
Siemens Healthineers
BD
Quidel
Bio-Rad
BioMerieux
Abaxis
Chembio
Sekisui Diagnostics
EKF Diagnostics
Trinity Biotech
Segment by Type
Instrument Systems
Tests Software & Services
Segment by Application
Clinics
Hospitals
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Rapid Point-of-Care (PoC) Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rapid Point-of-Care (PoC) Diagnostics companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rapid Point-of-Care (PoC) Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Point-of-Care (PoC) Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Instrument Systems
1.2.3 Tests Software & Services
1.3 Market by Application
1.3.1 Global Rapid Point-of-Care (PoC) Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rapid Point-of-Care (PoC) Diagnostics Market Perspective (2019-2030)
2.2 Global Rapid Point-of-Care (PoC) Diagnostics Growth Trends by Region
2.2.1 Rapid Point-of-Care (PoC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rapid Point-of-Care (PoC) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Rapid Point-of-Care (PoC) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Rapid Point-of-Care (PoC) Diagnostics Market Dynamics
2.3.1 Rapid Point-of-Care (PoC) Diagnostics Industry Trends
2.3.2 Rapid Point-of-Care (PoC) Diagnostics Market Drivers
2.3.3 Rapid Point-of-Care (PoC) Diagnostics Market Challenges
2.3.4 Rapid Point-of-Care (PoC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Rapid Point-of-Care (PoC) Diagnostics by Players
3.1.1 Global Rapid Point-of-Care (PoC) Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Rapid Point-of-Care (PoC) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Rapid Point-of-Care (PoC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rapid Point-of-Care (PoC) Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Rapid Point-of-Care (PoC) Diagnostics Market Concentration Ratio
3.4.1 Global Rapid Point-of-Care (PoC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Point-of-Care (PoC) Diagnostics Revenue in 2023
3.5 Global Key Players of Rapid Point-of-Care (PoC) Diagnostics Head office and Area Served
3.6 Global Key Players of Rapid Point-of-Care (PoC) Diagnostics, Product and Application
3.7 Global Key Players of Rapid Point-of-Care (PoC) Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Point-of-Care (PoC) Diagnostics Breakdown Data by Type
4.1 Global Rapid Point-of-Care (PoC) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Rapid Point-of-Care (PoC) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Rapid Point-of-Care (PoC) Diagnostics Breakdown Data by Application
5.1 Global Rapid Point-of-Care (PoC) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Rapid Point-of-Care (PoC) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rapid Point-of-Care (PoC) Diagnostics Market Size (2019-2030)
6.2 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Type
6.2.1 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Rapid Point-of-Care (PoC) Diagnostics Market Share by Type (2019-2030)
6.3 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Application
6.3.1 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Rapid Point-of-Care (PoC) Diagnostics Market Share by Application (2019-2030)
6.4 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country
6.4.1 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size (2019-2030)
7.2 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Type
7.2.1 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Rapid Point-of-Care (PoC) Diagnostics Market Share by Type (2019-2030)
7.3 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Application
7.3.1 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Rapid Point-of-Care (PoC) Diagnostics Market Share by Application (2019-2030)
7.4 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Country
7.4.1 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Rapid Point-of-Care (PoC) Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Rapid Point-of-Care (PoC) Diagnostics Market Size (2019-2030)
8.2 China Rapid Point-of-Care (PoC) Diagnostics Market Size by Type
8.2.1 China Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2019-2024)
8.2.2 China Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2025-2030)
8.2.3 China Rapid Point-of-Care (PoC) Diagnostics Market Share by Type (2019-2030)
8.3 China Rapid Point-of-Care (PoC) Diagnostics Market Size by Application
8.3.1 China Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2019-2024)
8.3.2 China Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2025-2030)
8.3.3 China Rapid Point-of-Care (PoC) Diagnostics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size (2019-2030)
9.2 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Type
9.2.1 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Rapid Point-of-Care (PoC) Diagnostics Market Share by Type (2019-2030)
9.3 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Application
9.3.1 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Rapid Point-of-Care (PoC) Diagnostics Market Share by Application (2019-2030)
9.4 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Region
9.4.1 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Rapid Point-of-Care (PoC) Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Rapid Point-of-Care (PoC) Diagnostics Introduction
11.1.4 Abbott Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Rapid Point-of-Care (PoC) Diagnostics Introduction
11.2.4 Roche Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.2.5 Roche Recent Developments
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher Rapid Point-of-Care (PoC) Diagnostics Introduction
11.3.4 Danaher Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.3.5 Danaher Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Rapid Point-of-Care (PoC) Diagnostics Introduction
11.4.4 Siemens Healthineers Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.4.5 Siemens Healthineers Recent Developments
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Rapid Point-of-Care (PoC) Diagnostics Introduction
11.5.4 BD Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.5.5 BD Recent Developments
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Rapid Point-of-Care (PoC) Diagnostics Introduction
11.6.4 Quidel Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.6.5 Quidel Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Rapid Point-of-Care (PoC) Diagnostics Introduction
11.7.4 Bio-Rad Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.7.5 Bio-Rad Recent Developments
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Rapid Point-of-Care (PoC) Diagnostics Introduction
11.8.4 BioMerieux Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.8.5 BioMerieux Recent Developments
11.9 Abaxis
11.9.1 Abaxis Company Details
11.9.2 Abaxis Business Overview
11.9.3 Abaxis Rapid Point-of-Care (PoC) Diagnostics Introduction
11.9.4 Abaxis Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.9.5 Abaxis Recent Developments
11.10 Chembio
11.10.1 Chembio Company Details
11.10.2 Chembio Business Overview
11.10.3 Chembio Rapid Point-of-Care (PoC) Diagnostics Introduction
11.10.4 Chembio Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.10.5 Chembio Recent Developments
11.11 Sekisui Diagnostics
11.11.1 Sekisui Diagnostics Company Details
11.11.2 Sekisui Diagnostics Business Overview
11.11.3 Sekisui Diagnostics Rapid Point-of-Care (PoC) Diagnostics Introduction
11.11.4 Sekisui Diagnostics Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.11.5 Sekisui Diagnostics Recent Developments
11.12 EKF Diagnostics
11.12.1 EKF Diagnostics Company Details
11.12.2 EKF Diagnostics Business Overview
11.12.3 EKF Diagnostics Rapid Point-of-Care (PoC) Diagnostics Introduction
11.12.4 EKF Diagnostics Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.12.5 EKF Diagnostics Recent Developments
11.13 Trinity Biotech
11.13.1 Trinity Biotech Company Details
11.13.2 Trinity Biotech Business Overview
11.13.3 Trinity Biotech Rapid Point-of-Care (PoC) Diagnostics Introduction
11.13.4 Trinity Biotech Revenue in Rapid Point-of-Care (PoC) Diagnostics Business (2019-2024)
11.13.5 Trinity Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott
Roche
Danaher
Siemens Healthineers
BD
Quidel
Bio-Rad
BioMerieux
Abaxis
Chembio
Sekisui Diagnostics
EKF Diagnostics
Trinity Biotech
听
听
*If Applicable.
